Avadel Pharma Earnings beat, Revenue Inline In Q3

  • Investing.com
Avadel Pharma Earnings beat, Revenue Inline In Q3
Credit: © Reuters.

Investing.com - Avadel Pharma reported third quarter earnings that beat analysts' expectations on Monday and revenue that was inline with forecasts.

The firm reported earnings per share of $-0.38 on revenue of $0.00. Analysts polled by Investing.com expected EPS of $-0.3867 on revenue of $0.00. .

Avadel Pharma shares gained 5.76% to trade at $11.020 in intra-day trade following the report.

For the year, Avadel Pharma shares are up 64.97%, outperforming the Nasdaq which is up 24.13% year to date.

Avadel Pharma follows other major Healthcare sector earnings this month


On Tuesday, October 19, 2021, J&J reported third quarter EPS of $2.6 on revenue of $23.34B, compared to forecasts of EPS of $2.35 on revenue of $23.64B.

Pfizer earnings beat analyst's expectations on Tuesday, November 2, 2021, with third quarter EPS of $1.34 on revenue of $24.09B. Investing.com analysts expected EPS of $1.08 on revenue of $22.58B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100